From Nasdaq: 2025-06-03 16:36:00

Quantum BioPharma Ltd. clarifies recent confusion over its name, confirming it has not changed to Unbuzzd Wellness Inc. There is no reverse takeover happening between the two companies. Unbuzzd, in which Quantum has a financial interest, is gearing up for a potential IPO, appointing MNP LLP for financial audits. Quantum remains the largest shareholder of Unbuzzd, with a 7% royalty on revenue until $250 million is paid. Unbuzzd’s leadership boasts industry veterans from Coca-Cola and Celsius Holdings. Quantum will settle vendor debt with Class B Shares. QNTM stock is trading at $15.20 on Nasdaq with no price change.



Read more at Nasdaq: Quantum BioPharma Clarifies Name Confusion, Refutes RTO Rumors With Unbuzzd Wellness